This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

What was the methodology and key findings?

Prescribing Information

Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of haematology patients in the UK

Mansour Ceesay, Consultant Haematologist, King’s College Hospital, NHS Foundation Trust

Length: 03:25

Questions addressed:

  • How did this study come about?
  • When you say cost what do you mean?

The study discussed in this video was supported by Gilead Sciences, Pfizer and Merck Sharp & Dohme (MSD) Limited who provided unrestricted educational grants for the project.

This study was published in the Journal of Antimicrobial Chemotherapy Volume 70, Issue 4, April 2015, pp. 1175– 1181.

More information about NOXAFIL® (posaconazole)